112 related articles for article (PubMed ID: 8265617)
1. Mevalonate availability and cardiovascular functions.
Roullet JB; Xue H; Pappu AS; Roullet C; Holcomb S; McCarron DA
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11728-32. PubMed ID: 8265617
[TBL] [Abstract][Full Text] [Related]
2. Proliferative effect of mevalonate metabolites other than isoprenoids on cultured vascular smooth muscle cells.
Sawamura M; Li N; Nara Y; Yamori Y
Clin Exp Pharmacol Physiol; 1993; 20(7-8):509-14. PubMed ID: 8403532
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin affects blood pressure and vascular reactivity.
Li N; Sawamura M; Nara Y; Ikeda K; Yamori Y
Heart Vessels; 1996; 11(2):64-8. PubMed ID: 8836753
[TBL] [Abstract][Full Text] [Related]
4. Mevalonate availability affects human and rat resistance vessel function.
Roullet JB; Xue H; Roullet CM; Fletcher WS; Cipolla MJ; Harker CT; McCarron DA
J Clin Invest; 1995 Jul; 96(1):239-44. PubMed ID: 7615793
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibitor affects blood pressure and vascular reactivity.
Li N; Sawamura M; Nara Y; Kizawa K; Ikeda K; Usui H; Kurahasi K; Yamori Y
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S316-7. PubMed ID: 9072408
[TBL] [Abstract][Full Text] [Related]
6. Alteration of enzyme expressions in mevalonate pathway: possible role for cardiovascular remodeling in spontaneously hypertensive rats.
Han J; Jiang DM; Du CQ; Hu SJ
Circ J; 2011; 75(6):1409-17. PubMed ID: 21467659
[TBL] [Abstract][Full Text] [Related]
7. Influence of gender on control of arterial tone in experimental hypertension.
Kähönen M; Tolvanen JP; Sallinen K; Wu X; Pörsti I
Am J Physiol; 1998 Jul; 275(1):H15-22. PubMed ID: 9688891
[TBL] [Abstract][Full Text] [Related]
8. Effect of lovastatin and fluoromevalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF.
Iwama A; Sawamura M; Nara Y; Yamori Y
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S318-20. PubMed ID: 9072409
[TBL] [Abstract][Full Text] [Related]
9. Effects of deoxycorticosterone on renal vascular reactivity and flow-pressure curve in spontaneously hypertensive rats.
Chamorro V; Moreno JM; Wangensteen R; Sainz J; Rodriguez-Gomez I; Osuna A; Vargas F
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):17-26. PubMed ID: 15082864
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate-independent pathways.
Sindermann JR; Schmidt A; Breithardt G; Buddecke E
Basic Res Cardiol; 2001; 96(3):283-9. PubMed ID: 11403422
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats.
Yang D; Félétou M; Boulanger CM; Wu HF; Levens N; Zhang JN; Vanhoutte PM
Br J Pharmacol; 2002 May; 136(1):104-10. PubMed ID: 11976274
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
Cuthbert JA; Lipsky PE
J Biol Chem; 1990 Oct; 265(30):18568-75. PubMed ID: 2211719
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-adrenoreceptor stimulation causes vascular smooth muscle cell hypertrophy: a possible role for isoprenoid intermediates.
Nishio E; Kanda Y; Watanabe Y
Eur J Pharmacol; 1998 Apr; 347(1):125-30. PubMed ID: 9650858
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol and mevalonic acid modulation in cell metabolism and multiplication.
Soma MR; Corsini A; Paoletti R
Toxicol Lett; 1992 Dec; 64-65 Spec No():1-15. PubMed ID: 1471162
[TBL] [Abstract][Full Text] [Related]
17. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
Ajay M; Achike FI; Mustafa MR
Pharmacol Res; 2007 May; 55(5):385-91. PubMed ID: 17317209
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive rats.
Yang D; Gluais P; Zhang JN; Vanhoutte PM; Félétou M
Fundam Clin Pharmacol; 2004 Jun; 18(3):321-6. PubMed ID: 15147283
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
Escobales N; Crespo MJ; Altieri PI; Furilla RA
J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
